PG
Therapeutic Areas
INOVIQ Pipeline
| Drug | Indication | Phase |
|---|---|---|
| hTERT ICC Test | Bladder Cancer (adjunct to urine cytology) | Commercial |
| EXO‑Ovarian Cancer Test | Ovarian Cancer | Phase 2/3 |
| NeuCA15‑3 Test | Breast Cancer Monitoring | Phase 1 |
| Exosome Therapeutics Platform | Solid Tumours | Preclinical |